Nanobio and Nanomedicine

Delivers innovative tools and solutions for Parallel Quantitative Biology (PQB) - contextual, systems-level measurements of genes, proteins and their cellular functions.

Parabon NanoLabs designs and develops a new class of therapeutics and other products made possible by proprietary technology for precisely directing the self-assembly of designer macromolecules that are functionalized with molecular subcomponents (e.g., enzymes, metals or pharmaceuticals).

Particle Sciences is an integrated provider of both standard and nanotechnology approaches to drug development and delivery. The company originally pioneered use of encapsulated ingredients and nanoparticles for sunscreens and personal care. In 1999 the company licensed a portion of its nanotechnology portfolio to BASF and focused its efforts on providing services to Life Sciences companies. Now, through a full range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution designed to minimize the time and risk between discovery and the clinic.

The company developed the Artiste™ Nano Composite System for dental restoration.

Active in the field of automating cell biology, the company's portfolio reaches from Optical Instruments and Automation Systems to Nano Liquid Handling Solutions and Cell Handling Devices.

Develops a Protected Graft Copolymer (PGC™) nano-carrier drug delivery system.

PharmaNova Inc. is a privately held, specialty drug development company founded on the re-purposing and enhancement of known drugs using our proprietary nanoparticle technology platform and other complementary formulation and drug delivery technologies.

A genomics company that has developed the world's first light-powered microtransponders and nanotransponders for performing nucleic acid-based assays.

Develops and sells patented high performance, injection-molded nanospray devices for mass spectrometry applications in drug discovery, clinical diagnostics and homeland security.

Piercell is a nanotechnology venture that is developing a biomolecular delivery device that pierces into primary and other hard-to-transfect cells. Piercell's vision is to pave the path to cell therapy by enabling ex vivo DNA and RNA drug delivery into clinically relevant cells of patients.

Pioneer Surgical Technology is a leading innovator in the design and manufacture of spinal and orthopaedic implants and instruments. The company's proprietary nanocrystalline hydroxyapatite technology - NanOss™ Bone Void Filler - is the first ever nanotechnology medical device to receive clearance by the US Food and Drug Administration (FDA). NanOss™ is an innovative structural biomaterial that is highly osteoconductive and remodels over time into human bone with applications in the sports medicine, trauma, spine and general orthopaedics markets.

The company develops, produces and markets nanotechnologies for the life sciences. They produce a variety of nano-structured surfaces for use in research and are also developing a range of products that derive from a proprietary platform technology using liquid crystals for the rapid detection of molecular interactions.

The company is specialized in developing cutting-edge nanoparticle technologies for the development of targeted drug delivery systems.

PolyRemedy, Inc. manufactures robotic systems for the fabrication of nano-material based wound dressings at the point-of-care, allowing wound care clinicians to deliver easily and cost-effectively customized wound care on-demand for each patient's unique wound.

A medical device company dedicated to reducing deaths from heart attacks The company applies nanotechnology techniques ot fabricating its stent products.

Promega's products are used in life science research, particularly in genomics, proteomics, and cellular analysis to support molecular diagnostics and human identification.

The company is developing intelligent medicine products internally and in partnership with device, pharmaceutical and biotechnology companies. These products address therapeutic areas where disease management complexity, patient monitoring requirements, therapeutic efficacy, and poor patient adherence create large clinical and commercial opportunities.

Protiva's 'SNALP' (for stable nucleic acid-lipid particles) are specialized lipid nanoparticles that fully encapsulate and systemically deliver a variety of nucleic acid molecules such as siRNA, aptamers and plasmid DNA.

Proxeon develops state-of-the-art solutions to solve many of the scientific and technical challenges that are faced by those working in the field of proteomics. The company's core competencies are in the areas of mass spectrometry, protein analysis, hardware and software design for proteome analysis.

A nanobiotechnology company developing commercializing drug delivery products and new nanostructured biomaterials.